Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.7K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.7K
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

1.1K
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
1.1K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

342
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
342
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

720
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
720
Bias01:22

Bias

8.1K
Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
8.1K
Test for Homogeneity01:23

Test for Homogeneity

2.6K
The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Use of Generative Artificial Intelligence in Systematic Literature Reviews: A Rapid Review of the Literature.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Projected health benefits and cost offsets from the United States National Hepatitis C Elimination Initiative.

Nature communications·2026
Same author

A Metamodel-Based General-Purpose Autocalibration Tool for Simulation Models.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same author

Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States.

Vaccines·2026
Same author

Economic Evaluation of PCV21 Use in Populations with Increasing Serotype 4 Invasive Pneumococcal Disease in the US: An Attributable Fraction Threshold Analysis.

Infectious diseases and therapy·2026
Same author

Cost-effectiveness of community-based interventions for reducing opioid overdose and non-overdose deaths: simulation modeling of HEALing Communities Study.

Lancet regional health. Americas·2026

Related Experiment Video

Updated: Apr 15, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

Characterizing Heterogeneity Bias in Cohort-Based Models.

Elamin H Elbasha1, Jagpreet Chhatwal

  • 1Health Economic Statistics, Merck Research Laboratories, Merck & Co. Inc., UG1C-60, PO Box 1000, North Wales, PA, 19454-1099, USA, elamin_elbasha@merck.com.

Pharmacoeconomics
|April 9, 2015
PubMed
Summary

Cohort-based models can underestimate life expectancy and other health outcomes due to heterogeneity bias. Understanding these biases is crucial for accurate cost-effectiveness analysis and decision-making in healthcare interventions.

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.3K

Related Experiment Videos

Last Updated: Apr 15, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.3K

Area of Science:

  • Health economics
  • Mathematical modeling
  • Biostatistics

Background:

  • Previous numerical studies indicated potential heterogeneity bias when using cohort-based models instead of individual-based models.
  • The direction of this bias (upward or downward) was not previously established.
  • Mathematical characterization is needed to understand bias direction in health economic models.

Purpose of the Study:

  • To mathematically characterize the conditions leading to upward or downward bias in cohort-based models.
  • To evaluate the impact of heterogeneity on cost-effectiveness outcomes.
  • To provide insights for comparative assessment of health economic models.

Main Methods:

  • Utilized a standard three-state disease progression model for cost-effectiveness evaluation.
  • Derived analytical expressions for life expectancy, quality-adjusted life years (QALYs), costs, and incremental net monetary benefits (INMB).
  • Investigated heterogeneity by varying model parameters individually and employed Jensen's inequality to determine bias direction.

Main Results:

  • Cohort-based approaches consistently underestimated life expectancy and QALYs.
  • Heterogeneity in disease progression led to overestimated costs but variable bias in QALYs gained, incremental costs, and INMB.
  • INMB was underestimated with heterogeneity solely in efficacy; bias was absent with heterogeneity only in cost or utilities.

Conclusions:

  • Cohort-based models without heterogeneity adjustment underestimate life expectancy and may inaccurately estimate other outcomes.
  • Characterizing bias is essential for accurate model comparison and informed healthcare decision-making.
  • Mathematical analysis clarifies the direction and conditions of bias in health economic modeling.